COVID-19 and "The Remdesivir Crosslet"
Abstract: Remdesivir has made an alleged comeback (with or without baricitinib) with the dawn of new COVID-19 strains internationally but back here in India it always was supposedly effective. However, not many studies could be published in support of the same (and thus the use of 'supposedly' apropos) from India given the confusing and changing guidelines world-around. Nevertheless, this article emphasizes the fact (by reporting cases of success) that remdesivir sure is effective albeit with the rider being the "timing" which we imagine as an 'appearance of a crosslet' in the fort of COVID-19.
Keywords: COVID-19, remdesivir
How to Cite?: Dr. Adwait Sodani, Dr. Haseena Begum, Dr. SK Nanda, "COVID-19 and "The Remdesivir Crosslet"", Volume 10 Issue 12, December 2021, International Journal of Science and Research (IJSR), Pages: 1155-1157, https://www.ijsr.net/getabstract.php?paperid=SR211210221525, DOI: https://dx.doi.org/10.21275/SR211210221525